Posts Tagged: Law and policy reform

We can’t end AIDS without tackling patent abuse

25 Jan 2020

News Opinion

Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...

Read more about We can’t end AIDS without tackling patent abuse

TEDWomen: Why are drug prices so high?

24 Jan 2020

News Opinion

Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...

Read more about TEDWomen: Why are drug prices so high?

The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries 

23 Sep 2019

News Opinion Research

A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...

Read more about The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries 

What’s wrong with IP rights? Protecting medicines from competition can be costly

22 Apr 2019

News

Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...

Read more about What’s wrong with IP rights? Protecting medicines from competition can be costly

Civil society key in TRIPS flexibility implementation

5 May 2018

News

Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...

Read more about Civil society key in TRIPS flexibility implementation